Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort.

Sakir Ahmed Pankti MehtaAby PaulS AnuSomy CherianVeena ShenoyKaveri K NaliandaSanjana JosephAnagha PoulosePadmanabha D Shenoy

Published in: Annals of the rheumatic diseases (2022)

Breakthrough infections occurred in 7.4% of patients and were associated with seronegativity following vaccination. This provides a basis for exploring postvaccination antibody titres as a biomarker in patients with AIRD.

Keyphrases

end stage renal disease
ejection fraction
coronavirus disease
sars cov
newly diagnosed
chronic kidney disease
prognostic factors
free survival
respiratory syndrome coronavirus